Antigenic structure, function, and evolution of the hemagglutinin- neuraminidase protein of human parainfluenza virus type 1

Journal of Infectious Diseases

Volumn 176, Issue 4, 1997, Pages 867-875

  Henrickson, Kelly J ^a,b   Savatski, Laura L ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEMAGGLUTININ; NEUTRALIZING ANTIBODY; SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL ACTIVITY; ARTICLE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; EVOLUTION; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; MONKEY; NONHUMAN; NUCLEIC ACID ANALYSIS; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA VIRUS INFECTION; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; VIRUS CARRIER;

EID: 0030863626     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516533     Document Type: Article

References (16)

1. Henrickson KJ, Ray R, Belshe RB. Parainfluenza. In: Mandell GL, Bennett JE, eds. Principles and practices of infectious diseases. 4th ed. New York: Churchill Livingston, 1994:1489-95.
2. Henrickson KJ, Kuhn SM, Savatski LL. Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis 1994;18:770-9.
3. Henrickson KJ. Monoclonal antibodies to human parainfluenza virus type 1 detect major antigenic changes in clinical isolates. J Infect Dis 1991;164:1128-34.
4. Henrickson KJ, Savatski L. Genetic variation and evolution of human parainfluenza virus type 1: analysis of 12 clinical isolates. J Infect Dis 1992;166:995-1005.
5. Henrickson KJ, Savatski LL. Two distinct human parainfluenza virus type 1 genotypes detected during the 1991 epidemic. J Clin Microbiol 1996;34:695-700.
6. Komada H, Kusagawa S, Orvell C, et al. Antigenic diversity of human parainfluenza virus type 1 isolates and their immunological relationship with Sendai virus revealed by using monoclonal antibodies. J Gen Virol 1992;73:875-84.
7. Hetherington SV, Watson AS, Scroggs RA, Portner A. Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages. J Infect Dis 1994;169:248-52.
8. Kasel JA, Frank AL, Keitel WA, et al. Acquisition of serum antibody to specific viral glycoproteins of parainfluenza virus 3 in children. J Virol 1984;52:828-32.
9. Spriggs MK, Murphy BR, Prince GA, et al. Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. J Virol 1987;61:3416-23.
10. Henrickson KJ, Kuhn SM, Savatski LL, Sedmak J. Recovery of human parainfluenza virus types one and two. J Virol Methods 1994;46:189-206.
11. Henrickson KJ, Kingsbury DW, Van Wyke Coelingh KL, Naeve CW, Portner A. Known neutralizing epitopes of human parainfluenza virus type 3 HN are conformational and cannot be imitated by synthetic peptides. Vaccine 1991;9:243-9.
12. Van Wyke Coelingh KL, Winter C, Murphy BR. Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus. Virology 1985;143:569-82.
13. Devereaux JP, Haeberli P, Smithies O. Comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 1988;12:387-95.
14. Tanaka Y, Galinski MS. Human parainfluenza virus type 3: analysis of the cytoplasmic tail and transmembrane anchor of the hemagglutinin-neuraminidase protein in promoting cell fusion. Virus Res 1995;36:131-49.
15. Bousse T, Takimoto T, Portner A. A single amino acid change enhances the fusion promotion activity of human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Virology 1995;209:654-7.
16. Takimoto T, Portner A. The human parainfluenza virus type-1 prototypic strain contains a heat-labile hemagglutinin-neuraminidase protein. Virus Res 1994;32:85-92.